Skip to content
  • Brazil
  • Canada
  • Europe
  • India
  • Italy
  • Japan
  • Korea
  • Latam
  • Russia
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
  • Language
  • +91 11 4925 6000
  • Request information
  • +91 11 4925 6000
  • Part of brands: |
IndiaIndia
  • Part of brands: |
  • We guide you
    • Fertility
    • Inherited diseases
    • Worry-free pregnancy
  • Reproductive Health
    • Specialists
      • SAT
      • CGT
      • PGT-A
      • PGT-M
      • PGS+ERA Synchrony
      • Embrace
      • ERA
      • EMMA
      • ALICE
      • Endometrio
      • Family POC
    • Patients
      • SAT
      • CGT
      • PGT-A
      • PGT-M
      • PGS + ERA Synchrony
      • Embrace
      • ERA
      • EMMA
      • Family POC
      • ALICE
      • Endometrio
  • Diagnostic
  • About us
    • Igenomix Research
    • About Igenomix
  • ACADEMY
Genetic Solutions > EndomeTRIO

EndomeTRIO: The endometrium matters

A new dimension of endometrial health to improve the reproductive prognosis of your patients.

  • Technical Overview
  • Documentation
  • Scientific evidence
  • I’m not a health specialist

EMMA + ALICE + ERA

A better understanding of endometrial health to improve you patient’s reproductive prognosis

30% of infertile women
have pathogenic bacteria

Are you interested?

Request information
Overview
  • EndomeTRIO
  • Benefits
  • Indications

Why does the endometrium matter?

The endometrium has been noted as a key factor for a healthy pregnancy in recent scientific studies. In fact, 20% of infertility is caused by the endometrial factor. [reference?]

Since 2014, Igenomix has been conducting a deep line of research to understand the role of the endometrial factor in recurrent implantation failure patients.

Our recent publications in the American Journal of Obstetrics and Gynecology (AJOG) demonstrate a new dimension of endometrial health that can improve your patient’s reproductive prognosis.

Which tests are included in EndomeTRIO?

ERA

The ERA test evaluates the receptivity of the endometrium to determine if, at the time of biopsy, the uterine lining is receptive to embryo implantation. This information allows us to determine the ideal time for a personalised embryo transfer (pET). The ERA test resulted in a 73% pregnancy rate in patients with implantation failure.

More info

EMMA

EMMA (Endometrial Microbiome Metagenomic Analysis) is a screening test to evaluate the endometrium at the microbiological level, improving clinical management of infertile patients.
By analysing the endometrial microbiome, EMMA determines whether the uterine microbial environment is optimal for embryo implantation.
EMMA provides information about the ten most abundant bacteria in the endometrium, recommending embryo transfer or appropriate treatment, depending on results.

More info

ALICE (Analysis of Infectious Chronic Endometritis) is a diagnostic test to detect the bacteria causing chronic endometritis (CE), a condition that is associated with infertility.
Independent studies show that this condition affects up to 30% of infertile patients, and in cases of repeated implantation failure or recurrent pregnancy loss, this can rise to 66%*.
ALICE identifies the most common bacteria causing CE and helps clinicians to recommend appropriate antibiotic and probiotic treatments.

More info

Who should use EndomeTRIO Analysis?

  • Women who have experienced implantation failure with morphologically good quality embryos
  • Women with a history of recurrent pregnancy loss
  • Women with a morphologically normal uterus and normal endometrial thickness (≥ 6 mm), where the physical features of the uterus and endometrium are unlikely to be the problem
  • Women with Chronic Endometritis

Methodology:

Only a single endometrial biopsy is needed to perform the combined ERA+EMMA+ALICE test, EndomeTRIO.

How should I and send the sample?

An endometrial biopsy taken from the uterine fundus must be immediately place into an ERA cryotube, shaken and stored in a refrigerator (4-8°C/ 39-46°F) for at least 4 hours.
Samples are sent at room temperature(<35ºC/95ºF) accompanied with the patient´s informed consent and a completed requisition form.

Test Limitations

  • Patients planning an assisted reproduction treatment
  • ERA test limitations
  • EMMA test limitations
  • ALICE test limitations
Documentation
  • Specialists’ documents

Clinical Sheet

Download

Brochure

Download

EndomeTrio Manual

Download
Scientific evidence

Relevant related studies:

Cicinelli et al. Reprod Sci 2014; 21(5):640-7.

Cicinelli et al. Hum Reprod. 2015; 30(2):323-30. 

Moreno I. et tal. Am J Obstet Gynecol, 2018, 218(6):602-602.

Moreno I. et tal. Am J Obstet Gynecol. 2016;215(6):684-703.


If you´re a little lost with this technical information...

Can we help you?

I’m not a health specialist

Igenomix and fertility

We work to make a world in which infertility is no longer an impossible barrier. Together with clinics and fertility specialists worldwide, we investigate human reproduction to change the lives of those who are trying to conceive.

Learn more about Igenomix

Other services

ERA

Evaluates the endometrial receptivity

More information

EMMA

Evaluates the endometrium at the microbiological level

More information

ALICE

Detects the bacteria causing chronic endometritis

More information

Sex selection and Sex determination, before and after conception is prohibited and punishable under PC & PNDT act no. 57 of 1994

Igenomix is in the media

IGENOMIX has not affiliated any news outlet or publication identified above. News coverage does not constitute an endorsement of IGENOMIX or its products
IGENOMIX_PartOfVitrolifeGroup_black

WE GUIDE YOU

Fertility
Inherited diseases prevention
Healthy pregnancy

OUR SERVICES

Genetic solutions
Learn about genetics
How to send a sample

ABOUT US

About Igenomix
Contact
Press and news
Quality
Work with us

FOLLOW IGENOMIX

Blog: Path to fertility

  +91 11 4925 6000
  Write us
  • Brazil
  • Canada
  • Europe
  • India
  • Italy
  • Japan
  • Korea
  • Latam
  • Russia
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
Language

[2024] © Igenomix Privacy policy Quality policy Legal note Cookies policy




  • We guide you
    • Fertility
    • Inherited diseases
    • Worry-free pregnancy
  • Reproductive Health
    • Specialists
      • SAT
      • CGT
      • PGT-A
      • PGT-M
      • PGS+ERA Synchrony
      • Embrace
      • ERA
      • EMMA
      • ALICE
      • Endometrio
      • Family POC
    • Patients
      • SAT
      • CGT
      • PGT-A
      • PGT-M
      • PGS + ERA Synchrony
      • Embrace
      • ERA
      • EMMA
      • Family POC
      • ALICE
      • Endometrio
  • Diagnostic
  • About us
    • Igenomix Research
    • About Igenomix
  • ACADEMY
  • Language
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT